Press Releases
Samsung Biologics participates in J.P. Morgan Healthcare Conference 2020
Samsung Biologics participates in J.P. Morgan Healthcare Conference 2020
Samsung Biologics will be participating in the 38th annual J.P. Morgan Healthcare Conference in San Francisco from 13th to 16th January.
The healthcare symposium brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community every year.
Dr. Tae Han Kim, CEO, and John Rim, EVP, will highlight the company’s achievements, goals, and vision through their presentation ‘SAMSUNG BIOLOGICS 2020 AND BEYOND - Fully Integrated Contract Services Company’ on Wednesday the 15th in the Grand Ballroom.
Invitation to the Grand Ballroom is symbolic in that the hall is always reserved for industry-leading companies such as Pfizer, Roche, and Johnson & Johnson.
Since 2017 Samsung Biologics was assigned to Main Track, a first for a Korean company.
It is the company’s second and consecutive year to be invited to speak in the Grand Ballroom.
Samsung Biologics participates in J.P. Morgan Healthcare Conference 2020
Samsung Biologics will be participating in the 38th annual J.P. Morgan Healthcare Conference in San Francisco from 13th to 16th January.
The healthcare symposium brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community every year.
Dr. Tae Han Kim, CEO, and John Rim, EVP, will highlight the company’s achievements, goals, and vision through their presentation ‘SAMSUNG BIOLOGICS 2020 AND BEYOND - Fully Integrated Contract Services Company’ on Wednesday the 15th in the Grand Ballroom.
Invitation to the Grand Ballroom is symbolic in that the hall is always reserved for industry-leading companies such as Pfizer, Roche, and Johnson & Johnson.
Since 2017 Samsung Biologics was assigned to Main Track, a first for a Korean company.
It is the company’s second and consecutive year to be invited to speak in the Grand Ballroom.